EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Enzyme for the Treatment of Osteosarcoma and Merkel Cell Carcinoma: Potential for the Development of a Targeted Therapeutic Strategy

Veronica Pompei, Monia Cecati, Emma Nicol Serritelli, Eleonora Gerini, Roberto Campagna iD, Valentina Pozzi iD, Matthijs J Van Haren, Nathaniel I Martin, Monica Emanuelli, Davide Sartini iD

Biomolecules · 2025

DOI: 10.3390/biom15111553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Veronica Pompei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Polytechnic University of Marche, 60126 Ancona, Italy. Hauptthemen laut MEDLINE: Osteosarcoma, Nicotinamide N-Methyltransferase, Carcinoma, Merkel Cell, Enzyme Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinamide N-methyltransferase (NNMT) enzyme catalyzes the N-methylation of nicotinamide and its overexpression has been reported in many neoplasms, favoring traits featuring an aggressive tumor cell phenotype. Our recent data demonstrated that NNMT upregulation in osteosarcoma (OS) and Merkel cell carcinoma (MCC) led to a significant increase in cell proliferation and migration ability, together with a reduction in sensitivity to chemotherapeutic treatment. Based on these findings, we investigated the impact of small molecule NNMT inhibitors 5-amino-1-methyl quinolinium (5-AMQ), 6-methoxynicotinamide (6MeONa) and Eli Lilly’s pyrimidine 5-carboxamide (EL-1) on U-2 OS and Saos-2 OS cell lines and MCC13 and MCC26 MCC cell lines. Following incubation of the cells with these compounds, cell viability, reactive oxygen species (ROS) production and apoptosis induction were evaluated. Cells were then subjected to combined treatment with inhibitors and cisplatin (CDDP), and viability and ROS levels were further analyzed. Our results clearly illustrate that cells treated with NNMT inhibitors underwent significant reductions in viability, increased ROS production and activation of apoptotic pathways. Given the association of NNMT with cancer aggressiveness, inhibiting its catalytic activity might present a novel strategy for counteracting cancer growth and chemoresistance, providing the rationale for an effective anti-cancer therapy based on the use of specific NNMT inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaNicotinamide N-MethyltransferaseCarcinoma, Merkel CellEnzyme InhibitorsAntineoplastic AgentsBone NeoplasmsSmall Molecule LibrariesHumansCell Line, TumorApoptosisReactive Oxygen SpeciesCell ProliferationCell SurvivalCisplatin

Stichwörter der Autor:innen

Merkel cell carcinomachemosensitivityenzyme inhibitorsnicotinamide N-methyltransferaseosteosarcomatargeted therapy

Substanzen

Nicotinamide N-MethyltransferaseEnzyme InhibitorsReactive Oxygen SpeciesAntineoplastic AgentsNNMT protein, humanCisplatinSmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Clinical Sciences, Polytechnic University of Marche, 60126 Ancona, Italy.
  • Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open University, 00166 Rome, Italy.
  • Biological Chemistry Group, Institute of Biology, Leiden University, 2311 Leiden, The Netherlands.
  • New York-Marche Structural Biology Center (NY-MaSBiC), Polytechnic University of Marche, 60121 Ancona, Italy.

ORCID-Profile: Roberto Campagna, Valentina Pozzi, Davide Sartini

Zitieren

APA

Pompei, V., Cecati, M., Serritelli, E. N., Gerini, E., Campagna, R., Pozzi, V., Van Haren, M. J., Martin, N. I., Emanuelli, M., & Sartini, D. (2025). Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Enzyme for the Treatment of Osteosarcoma and Merkel Cell Carcinoma: Potential for the Development of a Targeted Therapeutic Strategy. Biomolecules. https://doi.org/10.3390/biom15111553

Vancouver

Pompei V, Cecati M, Serritelli EN, Gerini E, Campagna R, Pozzi V, et al. Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Enzyme for the Treatment of Osteosarcoma and Merkel Cell Carcinoma: Potential for the Development of a Targeted Therapeutic Strategy. Biomolecules. 2025. doi:10.3390/biom15111553

BibTeX
@article{Pompei2025,
  author = {Pompei, Veronica and Cecati, Monia and Serritelli, Emma Nicol and Gerini, Eleonora and Campagna, Roberto and Pozzi, Valentina and Van Haren, Matthijs J and Martin, Nathaniel I and Emanuelli, Monica and Sartini, Davide},
  title = {Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Enzyme for the Treatment of Osteosarcoma and Merkel Cell Carcinoma: Potential for the Development of a Targeted Therapeutic Strategy},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15111553}
}
Kostenlos starten →